Uniform treatment thresholds for hyperbilirubinemia in preterm infants: Background and synopsis of a national guideline

Early Human Development

Volumn 87, Issue 8, 2011, Pages 521-525

  Van Imhoff, Deirdre Elisabeth ^a   Dijk, Peter Hendrik ^a   Hulzebos, Christian Victor ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Guidelines; Hyperbilirubinemia; Preterm infants; Risk factors; Treatment

Indexed keywords

ALBUMIN; BILIRUBIN;

ACIDOSIS; ARTICLE; BILIRUBIN BLOOD LEVEL; BIRTH WEIGHT; BODY TEMPERATURE DISORDER; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONVULSION; ECHOENCEPHALOGRAPHY; EXCHANGE BLOOD TRANSFUSION; FLUID INTAKE; FLUID RESTRICTION; GESTATIONAL AGE; HEMOLYSIS; HIGH RISK INFANT; HUMAN; HYPERBILIRUBINEMIA; LETHARGY; NETHERLANDS; NEWBORN; NEWBORN HYPOXIA; NEWBORN INTENSIVE CARE; NEWBORN JAUNDICE; NEWBORN SEPSIS; PHOTOTHERAPY; PRACTICE GUIDELINE; PREMATURITY; RESPIRATORY DISTRESS SYNDROME; RISK ASSESSMENT; RISK FACTOR; TOTAL SERUM BILIRUBIN; TREATMENT PLANNING;

BIRTH WEIGHT; EXCHANGE TRANSFUSION, WHOLE BLOOD; HUMANS; HYPERBILIRUBINEMIA, NEONATAL; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INTENSIVE CARE UNITS, NEONATAL; NETHERLANDS; PHOTOTHERAPY; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 79960440855     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2011.04.004     Document Type: Article

References (38)

1. Watchko J.F., Maisels M.J. Jaundice in low birthweight infants: pathobiology and outcome. Arch Dis Child Fetal Neonatal Ed 2003, 88:F455-F458.
2. Oh W., Tyson J.E., Fanaroff A.A., et al. Association between peak serum bilirubin and neurodevelopmental outcomes in extremely low birth weight infants. Pediatrics 2003, 112:773-779.
3. American Academy of Pediatrics Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004, 114:297-316.
4. Shapiro S.M. Definition of the clinical spectrum of kernicterus and bilirubin-induced neurologic dysfunction (BIND). J Perinatol 2005, 25:54-59.
5. Bhutani V.K., Maisels M.J., Stark A.R., et al. Management of jaundice and prevention of severe neonatal hyperbilirubinemia in infants>or=35weeks gestation. Neonatology 2008, 94:63-67.
6. Dijk P.H., de Vries T.W., de Beer J.J. Guideline 'Prevention, diagnosis and treatment of hyperbilirubinemia in the neonate with a gestational age of 35 or more weeks'. Ned Tijdschr Geneeskd 2009, 153.
7. Watchko J.F., Oski F.A. Kernicterus in preterm newborns: past, present, and future. Pediatrics 1992, 90:707-715.
8. Hansen T.W. Therapeutic approaches to neonatal jaundice: an international survey. Clin Pediatr (Phila) 1996, 35:309-316.
9. Rennie J.M., Seghal A., De A., et al. Range of UK practice regarding thresholds for phototherapy and exchange transfusion in neonatal hyperbilirubinaemia. Arch Dis Child Fetal Neonatal Ed 2008.
10. Maisels M.J., Watchko J.F. Treatment of jaundice in low birthweight infants. Arch Dis Child Fetal Neonatal Ed 2003, 88:F459-F463.
11. Pearlman M.A., Gartner L.M., Lee K., et al. Absence of kernicterus in low-birth weight infants from 1971 through 1976: comparison with findings in 1966 and 1967. Pediatrics 1978, 62:460-464.
12. Watchko J.F., Claassen D. Kernicterus in premature infants: current prevalence and relationship to NICHD Phototherapy Study exchange criteria. Pediatrics 1994, 93:996-999.
13. Maisels M.J. Clinical studies of the sequelae of hyperbilirubinemia. Hyperbilirubinemia in the newborn, Report of the 85th Ross Conference on Pediatric Research 1983, 26-38. Ross Laboratories, Columbus, OH. R.L. Levine (Ed.).
14. Dani C., Poggi C., Barp J., et al. Current Italian practices regarding the management of hyperbilirubinaemia in preterm infants. Acta Paediatr 2011.
15. Bratlid D., Nakstad B., Hansen T. National guidelines for treatment of jaundice in the newborn. Acta Paediatr 2010.
16. National Institute for Health and Clinical Excellence. Neonatal Jaundice 2010, (Clinical guideline 98). http://www.nice.org.uk/CG98.
17. Ahlfors C.E. Criteria for exchange transfusion in jaundiced newborns. Pediatrics 1994, 93:488-494.
18. Watchko J.F., Jeffrey Maisels M. Enduring controversies in the management of hyperbilirubinemia in preterm neonates. Semin Fetal Neonatal Med 2010, 15(3):136-140.
19. Shapiro S.M. Bilirubin toxicity in the developing nervous system. Pediatr Neurol 2003, 29:410-421.
20. Lucey J.F. The unsolved problem of kernicterus in the susceptible low birth weight infant. Pediatrics 1972, 49:646-647.
21. Lucey J.F. Hyperbilirubinemia of prematurity. Pediatrics 1960, 25:690-710.
22. Gartner L.M., Snyder R.N., Chabon R.S., et al. Kernicterus: high incidence in premature infants with low serum bilirubin concentrations. Pediatrics 1970, 45:906-917.
23. Newman T.B., Maisels M.J. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics 1992, 89:809-818.
24. Curtis-Cohen M., Stahl G.E., Costarino A.T., et al. Randomized trial of prophylactic phototherapy in the infant with very low birth weight. J Pediatr 1985, 107:121-124.
25. Jangaard K.A., Vincer M.J., Allen A.C. A randomized trial of aggressive versus conservative phototherapy for hyperbilirubinemia in infants weighing less than 1500g: short- and long-term outcomes. Paediatr Child Health 2007, 12:853-858.
26. Morris B.H., Oh W., Tyson J.E., et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight. N Engl J Med 2008, 359:1885-1896.
27. Lucey J.F. Neonatal jaundice and phototherapy. Pediatr Clin North Am 1972, 19:827-839.
28. Kim M.H., Yoon J.J., Sher J., et al. Lack of predictive indices in kernicterus: a comparison of clinical and pathologic factors in infants with or without kernicterus. Pediatrics 1980, 66:852-858.
29. Pearlman M.A., Gartner L.M., Lee K., et al. The association of kernicterus with bacterial infection in the newborn. Pediatrics 1980, 65:26-29.
30. Turkel S.B., Guttenberg M.E., Moynes D.R., et al. Lack of identifiable risk factors for kernicterus. Pediatrics 1980, 66:502-506.
31. Van de Bor M., Ens-Dokkum M., Schreuder A.M., et al. Hyperbilirubinemia in low birth weight infants and outcome at 5years of age. Pediatrics 1992, 89:359-364.
32. Levine R.L., Fredericks W.R., Rapoport S.I. Entry of bilirubin into the brain due to opening of the blood-brain barrier. Pediatrics 1982, 69:255-259.
33. Ebbesen F., Brodersen R. Risk of bilirubin acid precipitation in preterm infants with respiratory distress syndrome: considerations of blood/brain bilirubin transfer equilibrium. Early Hum Dev 1982, 6:341-355.
34. Satar M., Atici A., Oktay R. The influence of clinical status on total bilirubin binding capacity in newborn infants. J Trop Pediatr 1996, 42:43-45.
35. Muething S.E. Improving patient outcomes by standardizing care. J Pediatr 2005, 147:568-570.
36. Knupfer M., Pulzer F., Gebauer C., et al. Predictive value of umbilical cord blood bilirubin for postnatal hyperbilirubinaemia. Acta Paediatr 2005, 94:581-587.
37. Ebbesen F., Nyboe J. Postnatal changes in the ability of plasma albumin to bind bilirubin. Acta Paediatr Scand 1983, 72:665-670.
38. Papile L.A., Burstein J., Burstein R., et al. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500gm. J Pediatr 1978, 92:529-534.